Remove Production Remove Reagent Remove Recombinant DNA Technology
article thumbnail

TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress

The Pharma Data

TAKHZYRO is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology. Please consult the TAKHZYRO Summary Product Characteristics (SmPC) before prescribing.?. The reagents used in the aPTT laboratory test initiate intrinsic coagulation through the activation of plasma kallikrein in the contact system.